MARATTO

review · Ageing Research Reviews

Reducing Alzheimer’s disease risk with SGLT2 inhibitors: From glycemic control to neuroprotection

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Diabetes Treatment and Management
  • Apelin-related biomedical research
  • Pancreatic function and diabetes

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.arr.2025.102751

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.